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Abstract 
Introduction 
The study describes bothersome lower urinary tract symptoms, risk factors and 
associated functional abnormalities in women reporting adult onset secondary 
nocturnal enuresis (SNE), to help understand factors associated with SNE. 
Methods 
12795 women (age ≥ 18) attending a tertiary referral centre underwent a 
comprehensive standardized evaluation including urodynamic testing in 
accordance with International Continence Society recommendations. Records 
of all patients reporting bedwetting whilst asleep were evaluated under various 
categories. Multiple logistic regression was fitted to identify statistically 
significant risk factors and urodynamic findings associated with SNE. 
Results 
The prevalence of SNE in women undergoing urodynamic testing for 
bothersome lower urinary tract symptoms was 14.4% (1838). High BMI (OR= 
1.47, p< 0.001), cigarette smoking (OR= 2, p< 0.001), antidepressant usage 
(OR= 1.8, p< 0.001), neurological conditions (OR= 2.12, p< 0.001) and 
previous hysterectomy (OR= 1.19, p= 0.03) were significantly associated with 
SNE. Women with SNE significantly complained of overactive bladder (OAB) 
symptoms (OR= 1.65, p< 0.001) and slightly higher mean nocturia episodes 
(OR= 1.38, p< 0.0001). Low maximum urethral closure pressure (MUCP) (OR= 
1.34, p<0.0001) and detrusor overactivity incontinence (DOI) (OR= 1.75, 
p<0.0001) were significantly associated with SNE. There was no significant 
association with the symptom of stress urinary incontinence (p= 0.264), 
urodynamical stress incontinence (p= 0.454) or detrusor overactivity (p= 0.231).  
Conclusion 
Adult SNE is rarely monosymptomatic and patients usually present with OAB 
symptoms. SNE is associated with high BMI, cigarette smoking, antidepressant 
use and neurological conditions. DOI and a low MUCP are possible 
pathophysiological mechanisms in SNE.  
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Nocturnal enuresis (NE) is a highly bothersome lower urinary tract symptom 
(LUTS) described as involuntary loss of urine which occurs during sleep 
(Haylen et al. 2010). NE can be considered as primary (life-long) or secondary 
(arising after a period without bedwetting of at least one year). It can also be 
monosymptomatic or polysymptomatic (arising in conjunction with other 
symptoms). NE is common in children and at five years of age up to 25% of 
children wet the bed (Wan & Greenfield 1997). With each year of maturity the 
percentage of bed wetting declines by 15 percent. Eight percent of twelve year 
old boys and four percent of 12 year old girls are enuretic, and this number at 
adolescence is between one and three percent (Thiedke 2003). Longitudinal 
follow up studies have suggested that 3% of adults over 20 years of age remain 
enuretic from childhood and are at risk of remaining enuretic for the rest of their 
lives (Moilanen et al. 1998; Forsythe & Redmond 1974). However, NE may 
develop as a new symptom in adults after achieving control for a reasonable 
period of time (adult onset secondary nocturnal enuresis). Adult onset 
secondary nocturnal enuresis is the focus of investigation in this paper and will 
henceforth be referred to as SNE. The prevalence of SNE in women, especially 
with LUTS, is not known. A large epidemiological survey from the Netherlands 
suggested an overall prevalence of NE of 0.5% in non-institutionalized adults 
aged between 18 to 64 years, with no difference in age groups or sexes 
(Hirasing et al. 2009).  
Various mechanisms, including deficient vasopressin release, sleep disorders, 
psychosocial problems, genetic factors and anatomical bladder problems, have 
been implicated in the pathophysiology of NE (Thiedke 2003; Hirasing et al. 
2009; Yeung 2003; Wolfish 2001; Umlauf & Chasens 2003). A reduction in the 
bladder capacity has been suggested by some studies (C K Yeung et al. 2002), 
whilst this is not shown as a significant finding in other studies (Nørgaard & 
Djurhuus 1993). Detrusor overactivity (bladder instability) has also been 
implicated in the pathophysiology of NE (C K Yeung et al. 2002; Warwick & 
Whiteside 1979). NE in men has been suggested as a sign of a high pressure 
chronic urinary retention due to urethral outflow resistance, with a 
recommendation for investigations and treatment (SAKAMOTO & BLAIVAS 
2001; Abeygunasekera & Goonesinghe 2013). Even though urodynamic 
investigations have been used in the assessment of adults with NE with or 
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without other lower urinary tract symptoms, NE is still poorly understood, 
making management challenging. 
 
This study is a review of findings in all women (≥18 years of age) reporting 
nocturnal enuresis when presenting for urodynamic testing for various LUTS. 
The study attempts to characterise specific risk factors and urodynamic findings 
to further our understanding. The aim is to draw conclusions to recommend 
further research and help manage women with this distressing condition.  
 
Methodology: 
The study was registered with the Research and Innovation department, 
Southmead Hospital, Bristol. Ethical approval was obtained from the regional 
research ethics committee. All patients were seen in the Department of 
Urodynamics (Bristol Urological Institute) at Southmead Hospital, Bristol. 
Patients were referred from local, regional and national centres for urodynamic 
assessment. All patients were sent an information leaflet regarding the 
urodynamic procedure along with their appointment letter. A team of doctors 
and specialist urodynamic nurses saw the patients. Verbal consent was 
obtained prior to performing the test. A complete history and a pelvic 
examination were done in all patients. A urine analysis was carried out to rule 
out any infections in all the patients. Invasive and non-invasive urodynamic 
tests were done in all the patients according to the recommendations of the 
International Continence Society (ICS) . Frequency volume charts of all the 
patients who filled them out were analyzed, but only mean daytime frequency 
and nocturia episodes were entered on to the database. All the patients 
reporting adult onset bedwetting (SNE) were included in the study. Patients with 
primary nocturnal enuresis (since childhood), with no period of remission, were 
excluded from the study. Patients aged less than 18 years were also excluded 
from this study. Data including history and urodynamic findings were kept on a 
secure database maintained by the North Bristol NHS Trust, Bristol. All the 
Trust standard operating procedures and policies were followed in the 
collection and analysis of the data for this study. Data was analyzed as a whole 
group and also considered under various associated conditions. NE was also 
considered in patients with or without overactive bladder symptoms. NE was 
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also considered in groups according to cigarette smoking, antidepressant use 
and associated neurological conditions. 
Data from the urodynamic database was anonymized and cleaned for clarity, 
and then analyzed using SPSS (IBM SPSS Statistics for Windows, Version 
21.0. Armonk, NY: IBM Corp). Student’s t-test was used for testing differences 
in the mean between two continuous variables, while a Chi-square test was 
used for testing associations between categorical variables. A multiple logistic 
regression analysis was done with all the covariates in the model to evaluate 
the risk factors and urodynamic findings associated with SNE. Unless specified 
otherwise, all tests were made at a 5% level of significance. Whenever 
appropriate, p-values, Odds ratios and 95% confidence intervals were 
computed and included in the result. 
 
Results 
Data from 12795 women who underwent urodynamics for various LUTS during 
the study period (January 2000 to December 2010) were reviewed. 1838 
women (study group) aged ≥18 years complained of secondary nocturnal 
enuresis in this study, with a prevalence rate of 14.4%. The demographic details 
of all the patients in the study are summarized in table 1. The average age of 
women in the study group was 52.6 years (compared to 52.5 in the control 
group; p= 0.961). The mean parity of women with SNE was 2.4, which was the 
same in the control group. High BMI (> 30) was significantly associated with 
SNE in women (27.4% Vs. 19.4%; OR= 1.47, p< 0.0001).  A greater proportion 
of women with SNE also smoked cigarettes (30.1% Vs. 15.9%; OR= 2.03, p< 
0.001) and reported using anti-depressant medications (16.3% Vs. 8.5%; OR= 
1.795, p< 0.001). Neurological conditions like cerebro-vascular accidents and 
multiple sclerosis were significantly higher in women with SNE (10.3% Vs. 
5.2%; OR= 2.12, p< 0.001). Previous hysterectomy was also significantly 
associated with SNE (36% Vs. 30.3%; OR= 1.19, p= 0.032). Menopausal status 
was not significantly associated with SNE (p=0.638).  
 
Important LUTS and urodynamic findings are summarized in table 2. The mean 
daytime frequency in women with SNE was 8.3 (SD= 3.4), which was slightly 
higher compared to 7.95 in the control group (OR= 0.97, p= 0.03). The mean 
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nocturia severity was 1.76 voids per night (SD = 2.8) in women with SNE, 
compared to 1.26 in the control group, which was statistically highly significant 
(OR= 1.38, p < 0.001). More women with SNE reported overactive bladder 
(OAB) symptoms (82.6% Vs. 62.6%; OR= 1.65, p< 0.001). Prevalence of the 
symptom of stress incontinence was not significantly different between the 
groups at history taking (p= 0.264).  
 
At uroflowmetry, a higher proportion of women with SNE (8.1% Vs. 7.1%) had 
post-void residual volume of urine of > 150 ml, (OR = 1.6, p< 0.001). The mean 
residual volume of urine retained in women with significant PVR (> 150 ml) was 
325.8 ml compared to 269.1 ml in the control group, which was significant (p= 
0.001). The average flow rate was slightly less in the SNE group (21.1 ml/s Vs. 
21.9 ml/s, p= 0.017). Women with SNE had a significantly lower cystometric 
capacity (219.2 ml Vs. 344.5 ml, p < 0.001).  
 
41.1% of women with SNE had low maximum urethral closure pressures 
compared to 37.9% in the control group, which was statistically significant (OR= 
1.34, p< 0.001). Detrusor overactivity was seen in 55.8% of the study group 
(compared to 40.3% in the control) but this was not statistically significant (p= 
0.231). Detrusor overactivity incontinence was demonstrable in 22.9% of 
women in the study group (22.9% Vs. 12.4%; OR= 1.75, p< 0.001), which was 
statistically highly significant. Neither a symptom of SUI (p= 0.264) nor a 
urodynamic finding of UDSI (p= 0.454) were significantly associated with SNE. 
A combination of UDSI with DOI (mixed UI) was significantly more prevalent in 
the SNE group (37.3% Vs. 21.5%; OR= 1.64, p < 0.001).  
 
Discussion 
SNE is a common condition reported by adult women presenting with 
bothersome LUTS. SNE is significantly associated with overactive bladder 
symptoms and urinary incontinence. High BMI, cigarette smoking, anti-
depressant usage were the most significant risk factors associated with SNE. 
Neurological conditions and pervious hysterectomy were also significantly 
associated with SNE. Detrusor overactivity incontinence and a low MUCP were 
the most common associated urodynamic findings.  
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A prevalence of 14.4% of SNE in women presenting with bothersome LUTS for 
urodynamic testing suggests a high prevalence of this poorly studied condition. 
Epidemiological studies in adult populations quote a prevalence rate of around 
3% in adult population (Moilanen et al. 1998; Forsythe & Redmond 1974). A 
large epidemiological survey suggested an overall prevalence of SNE at 0.5% 
in non-institutionalized adults (18 – 64 years) (Hirasing et al. 2009). A study 
based on a database review of 3000 patients of adult onset nocturnal enuresis 
without daytime incontinence quoted a prevalence rate of 0.02% (Schäfer et al. 
2002). Our study was based on a large database of adult women who 
presented with various lower urinary tract symptoms indicating a higher 
prevalence of SNE in adult women with LUTS. It is an indication of the 
polysymptomatic nature of the problem. It may also be an indication of how 
women respond to other LUTS in association with SNE, which also reflects their 
healthcare seeking behavior.  
 
The majority of SNE patients in our study complained of overactive bladder 
symptoms (OR= 1.65) and nocturia (OR= 1.38) was a significant association 
with SNE. SNE is a nighttime problem; it is possible that women get up more 
often to ensure that they empty their bladder to avoid SNE episodes. Nocturnal 
polyuria and abnormal diurnal rhythm of plasma vasopressin are suggested as 
possible mechanisms for NE (Kamperis et al. 2006; Rittig et al. 1989), which 
could explain this finding. The database however, did not provide data on 
nighttime voided volumes and hence we were unable to analyze this data 
further. DO was more prevalent with SNE but this was not statistically 
significant. DOI (OR= 2.16) was the most significant urodynamic finding 
demonstrated in women with SNE, which suggests a dysfunction of the bladder 
detrusor as an important mechanism in the pathophysiology of SNE. Detrusor 
overactivity has been reported in other studies as one of the predominant 
urodynamic findings, and an important factor in the pathophysiology of NE 
(Wadie 2004; Foldspang & Mommsen 1994). A genetic inheritance of SNE with 
associated DO has also been proposed (Chiozza et al. 1998). Current evidence 
is conflicting on the role of reduced bladder capacity in the pathophysiology of 
nocturnal enuresis (Ciftci et al. 2012; Kamperis et al. 2006; Lin et al. 2004). The 
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mean maximum cystometric capacity was slightly lower in women with SNE in 
our study (mean difference of 53.3, p< 0.001), which does indicate a lower 
bladder capacity as a possible factor in the pathogenesis of NE.  A low MUCP 
was an independent risk factor associated with SNE and was significantly low 
in the study group, also suggesting a possible role in the etiopathogenesis of 
SNE. High maximum urethral closure pressure suggestive of obstruction was 
not noted in our cases, which is in contrast to some studies suggesting retention 
with outflow obstruction (C K Yeung et al. 2004).  A smaller bladder with 
detrusor dysfunction and a low MUCP may suggest a possible mechanism of 
adult bed-wetting. A significant proportion of women with SNE did not complain 
of stress incontinence, and UDSI was not a significant association, which 
indicates that stress incontinence is unlikely to have a role in SNE.  
 
Cigarette smoking is associated with overactive bladder symptoms and 
detrusor overactivity (Tampakoudis et al. 1995; Dallosso et al. 2003). Smoking 
was a significant finding associated with SNE in our study (OR= 2.26). Nicotine, 
a nicotinic acetylcholine receptor (nAChRs) agonist, has a role in the 
modulation of neurotransmitter release in both the central and peripheral 
nervous systems resulting in detrusor contractile responses (Masuda et al. 
2006). It is however difficult to establish a causal role of smoking based on this 
study. Obesity is a known risk factor for both stress and urgency urinary 
incontinence (Mayo & Burns 1990; Whiteside & Arnold 1975; Chung Kwong 
Yeung et al. 2002). Even though the mechanism is not fully understood on its 
role in UUI, obesity may cause chronic strain, stretching and weakening the 
muscles, nerves and other pelvic floor structures (Subak et al. 2009). Obesity 
may also have an effect on nerve conduction velocities, affecting neuronal 
control of the urinary bladder and contributing to DOI, and in turn SNE (Miscio 
et al. 2005). Some of these mechanisms may explain the significant association 
of a high BMI with SNE in the study group.  
 
Even though we have not used any objective tools to measure depression, 
16.3% of our patients reported using antidepressants (OR= 2.1, p<0.001). This 
data could be an indication of a higher association of depression with nocturnal 
enuresis or may indicate a higher antidepressant usage in women with SNE. It 
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is difficult to establish a causal relationship based on the data from our study. 
It is known that NE is associated with depression and low self-esteem in adults 
(Chung Kwong Yeung et al. 2004). NE might be associated with hypnotic 
medications (Vural et al. 2007). Antidepressants may also interfere with arousal 
mechanisms at night, which may lead to nocturnal enuresis (Neveus 2003). 
Disorders of sleep and arousal have been implicated in the pathophysiology of 
NE (Umlauf & Chasens 2003; Wolfish 2001). No information could be drawn 
from the database to evaluate arousal and sleep to explain this finding further.  
 
The integrity of the central nervous system, nervous control of the bladder and 
the arousal system of the central nervous system are crucial for maintenance 
of nighttime bladder function (Fowler et al. 2008). A tenth of all our cases with 
nocturnal enuresis developed secondary nocturnal enuresis in association with 
a neurological pathology, which indicates a disruption in the neuronal pathways 
controlling the bladder. Damage to the neuronal circuits, either at the brain or 
spinal cord, results in unmasking of primitive voiding reflexes and trigger 
detrusor overactivity and incontinence (de Groat 1997). This may also explain 
the higher incidence of detrusor overactivity in these cases and explain the 
associated SNE.  
 
This study is an evaluation of urodynamic findings of individuals complaining of 
SNE with or without other lower urinary tract symptoms. SNE alone was not the 
primary focus of the urodynamic testing in many of the cases, but was routinely 
questioned at history taking. Cystometric tests were done methodologically as 
per ICS recommendations, which provide valuable data for interpretation and 
understanding of SNE. All the patients in the study were awake and the test 
results are an indirect reflection of a problem which occurs when asleep. 
Urodynamic assessments were conducted when the subjects were awake and 
hence the findings must be interpreted as only associations. Treatment 
received and outcomes of treatment were also not available from the database, 
and some of the cases were referred from other centres for urodynamic testing 
only. These factors do limit further correlation of the urodynamic findings to 
patient symptoms and outcomes of treatment. Further long-term longitudinal 
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studies exploring OAB symptoms and NE are needed to understand symptoms 
emergence and etiopathogenesis of SNE. 
 
Conclusion 
Patients with adult SNE usually present with OAB symptoms. High BMI, 
cigarette smoking, antidepressant use and neurological conditions are 
significant risk factors associated with SNE. A low bladder capacity, detrusor 
overactivity incontinence and low MUCP are the most significant urodynamic 
findings associated with SNE. Further studies are needed to evaluate the 
importance of these findings on treatment outcomes of patients with NE.  
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NE  Nocturnal enuresis 
SNE  Adult onset secondary nocturnal enuresis 
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DO  Detrusor overactivity 
UDSI  Urodynamic stress incontinence 
UPP  Urethral pressure profile 
OAB  Overactive bladder 
BMI  Body mass index 
NAD  Nothing abnormal detected 
ICS  International continence society 
PVR  Post-void residual volume of urine 
MUCP Maximum urethral closure pressure 
UUI  Urgency Urinary Incontinence 
 
 
 
